GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » 12-1 Month Momentum %

Pharma Equity Group A/S (OCSE:PEG) 12-1 Month Momentum % : -42.73% (As of Jun. 12, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-12), Pharma Equity Group A/S's 12-1 Month Momentum % is -42.73%.

The industry rank for Pharma Equity Group A/S's 12-1 Month Momentum % or its related term are showing as below:

OCSE:PEG's 12-1 Month Momentum % is ranked worse than
67.55% of 1479 companies
in the Biotechnology industry
Industry Median: -23.82 vs OCSE:PEG: -42.73

Competitive Comparison of Pharma Equity Group A/S's 12-1 Month Momentum %

For the Biotechnology subindustry, Pharma Equity Group A/S's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Equity Group A/S's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group A/S's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group A/S's 12-1 Month Momentum % falls into.



Pharma Equity Group A/S  (OCSE:PEG) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Equity Group A/S  (OCSE:PEG) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Pharma Equity Group A/S 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Equity Group A/S (OCSE:PEG) Business Description

Traded in Other Exchanges
N/A
Address
Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970
Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.